Schering gets Japanese rights to Epix's MRI agent

EPIX granted SHR exclusive rights to co-develop and market in Japan EPIX's MS-325 cardiovascular magnetic resonance imaging agent (MRI). SHR already has MS-325 rights in the rest of the world (see Bi...